---
title: "Urine-based Mtb antigen detection for childhood TB using an ultrasensitive ECL immunoassay"
id: "medrxiv-16-the-accuracy-of-urine-based-mycobacterial-antigens-to-detect-childhood"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-16-the-accuracy-of-urine-based-mycobacterial-antigens-to-detect-childhood"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.28.26361530v1?rss=1"
published_at: "2026-09-02T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Urine-based Mtb antigen detection for childhood TB using an ultrasensitive ECL immunoassay
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-16-the-accuracy-of-urine-based-mycobacterial-antigens-to-detect-childhood
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.28.26361530v1?rss=1)
- **Published At:** 2026-09-02T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Urine-based testing may provide a non-sputum approach to diagnose **paediatric tuberculosis**, addressing challenges of obtaining respiratory samples in children. - Investigators developed an ultrasensitive multiplex electrochemiluminescence (**ECL immunoassay**) to measure five mycobacterial antigens: **Ag85B**, CFP-10, ESAT-6, MPT32, and MPT64, alongside lipoarabinomannan (**LAM**). - The analytical limits of detection were femtomolar (1.5–4.0 fM). - The study analysed urine from 630 children enrolled across five high-burden countries; median age 4 years, 44% female, 15% HIV-positive, 19% underweight, 24% with Confirmed pulmonary TB. - Individual **Mtb proteins** had high specificity (98–100%) but low sensitivity (12–33%) for Confirmed TB; **Ag85B** had the highest sensitivity at 33% (95% CI 26–41) and performed similarly to **LAM**. - A four-antigen signature (Ag85B, MPT64, MPT32, LAM) achieved 50% sensitivity (95% CI 42–58) and 94% specificity (95% CI 90–96), significantly more sensitive than LAM alone, particularly in children without HIV. - Sixteen children (10% of those with Unconfirmed TB) had at least one Mtb protein or LAM detected, suggesting potential to reclassify some unconfirmed cases. - Findings indicate multi-antigen urine detection can augment sensitivity while maintaining high specificity and provide analytical targets for future point-of-care diagnostics. - Funding was from the National Institutes of Health; several authors are employees or have ownership interest in Meso Scale Diagnostics, LLC. - Ethical approvals were obtained from multiple institutional review boards across participating sites.
## Clinical Analysis & Structured Key Points
The accuracy of urine-based mycobacterial antigens to detect childhood tuberculosis using an ultrasensitive immunoassay | medRxiv Skip to main content The accuracy of urine-based mycobacterial antigens to detect childhood tuberculosis using an ultrasensitive immunoassay Esin Nkereuwem , Salvia Misaghian , Devan Jaganath , Roger I Calderon , Juaneta Luiz , Mandar Paradkar , Peter Wambi , Robert Castro , Rutuja Nerurkar , Mingyue Wang , Jacob Wohlstadter , Molly F Franke , Beate Kampmann , Aarti Kinikar , Heather J Zar , Mark Segal , Midori Kato-Maeda , Jeffrey M Collins , Danielle Swaney , Adithya Cattamanchi , Joel D Ernst , Eric Wobudeya , View ORCID Profile George Sigal , The Combo Study doi: https://doi.org/10.64898/2026.08.28.26361530 Esin Nkereuwem 1 London School of Hygiene and Tropical Medicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Salvia Misaghian 2 Meso Scale Diagnostics, LLC.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Devan Jaganath 3 University of California San Francisco; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Roger I Calderon 4 Advanced Research and Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Juaneta Luiz 5 University of Cape Town; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mandar Paradkar 6 Byramjee Jeejeebhoy Government Medical College; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Peter Wambi 7 WALIMU; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Robert Castro 3 University of California San Francisco; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Rutuja Nerurkar 3 University of California San Francisco; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mingyue Wang 2 Meso Scale Diagnostics, LLC.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jacob Wohlstadter 2 Meso Scale Diagnostics, LLC.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Molly F Franke 8 Harvard Medical School; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Beate Kampmann 9 Charité Universitätsmedizin Berlin; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Aarti Kinikar 6 Byramjee Jeejeebhoy Government Medical College; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Heather J Zar 5 University of Cape Town; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mark Segal 3 University of California San Francisco; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Midori Kato-Maeda 3 University of California San Francisco; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jeffrey M Collins 10 Emory University School of Medicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Danielle Swaney 3 University of California San Francisco; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Adithya Cattamanchi 11 University of California Irvine Find this author on Google Scholar Find this author on PubMed Search for this author on this site Joel D Ernst 3 University of California San Francisco; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Eric Wobudeya 7 WALIMU; Find this author on Google Scholar Find this author on PubMed Search for this author on this site George Sigal 2 Meso Scale Diagnostics, LLC.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for George Sigal For correspondence: gsigal{at}alum.mit.edu Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background. Urine-based testing offers a promising non-sputum approach for diagnosing paediatric tuberculosis. However, the currently available lipoarabinomannan (LAM) assay shows limited sensitivity in children and is primarily indicated for those living with HIV. Co-detection of LAM with Mycobacterium tuberculosis (Mtb) proteins in urine could provide complementary pathogen-derived biomarkers that improve diagnostic performance. Methods. We developed an ultrasensitive multiplex electrochemiluminescence (ECL) immunoassay to measure Ag85B, CFP-10, ESAT-6, MPT32, and MPT64 in urine. We determined the analytical limits of detection and evaluated the diagnostic performance of individual proteins and LAM using urine samples from children with Confirmed, Unconfirmed, and Unlikely pulmonary tuberculosis enrolled across five high-burden countries (The Gambia, India, Peru, South Africa, and Uganda). Performance was assessed overall, by HIV and nutritional status, and across biomarker combinations. Findings. Urine samples from 630 children were analysed (median age was 4 years [IQR 2-8]; 44% female, 15% living with HIV, 19% underweight, 24% with Confirmed tuberculosis). The ECL assay achieved femtomolar limits of detection (1.5 to 4.0 fM). The sensitivity and specificity of individual Mtb proteins were 12-33% and 98-100%, respectively. Ag85B had the highest sensitivity (33%, 95% CI 26-41) for Confirmed tuberculosis and was similar to LAM. A four-antigen signature (Ag85B, MPT64, MPT32, LAM) was 50% sensitive (95% CI 42-58) and 94% specific (95% CI 90-96), and was significantly more sensitive than LAM alone, in particular among those without HIV. An additional sixteen (10%) of children with Unconfirmed TB had at least one Mtb protein or LAM detected. Interpretation. Multiple Mtb proteins are detectable in paediatric urine with high specificity, and multi-antigen signatures can augment sensitivity versus LAM alone. These findings demonstrate the potential of multi-antigen urine detection for childhood TB and define analytical targets for the development of future point-of-care diagnostics. Funding. National Institutes of Health. Competing Interest Statement SM, MW, JW and GBS are all employees, and JW has an ownership interest, at Meso Scale Diagnostics, LLC. MSD and the funding agencies did not have any role in the decision to publish. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Ethics Research Committee of the Mulago Hospital gave ethical approval for this work. The Joint Ethics Committee of the Gambian Government and MRC gave ethical approval for this work. The Research Ethics Committee of the London School of Hygiene and Tropical Medicine gave ethical approval for this work. The Institutional Ethics Committee of the Research of National Institute of Health - Peru gave ethical approval for this work. The Human Research Ethics Committee of the Faculty of Health Sciences, University of Cape Town, gave ethical approval for this work. The Ethics Committee of the BJ Government Medical College gave ethical approval for this work. The Institutional Review Board (IRB) of Johns Hopkins University (JHU) gave ethical approval for this work. The IRB of the University of California, San Francisco (UCSF) gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability De-identified individual participant data that underline the results reported in this article, with data dictionary, are available following publication by researchers who provide a methodologically sound proposal that is approved by the study investigators. Please contact the corresponding author to share a proposal; all requesters will also need to sign a data sharing agreement. Funder Information Declared National Institute of Allergy and Infectious Diseases, https://ror.org/043z4tv69 , R01AI152161 , U01AI152087 , U19AI109755 RePORT Internaitional Coordinating Center , DAA3-18-64080-1 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted September 02, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following The accuracy of urine-based mycobacterial antigens to detect childhood tuberculosis using an ultrasensitive immunoassay Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share The accuracy of urine-based mycobacterial antigens to detect childhood tuberculosis using an ultrasensitive immunoassay Esin Nkereuwem , Salvia Misaghian , Devan Jaganath , Roger I Calderon , Juaneta Luiz , Mandar Paradkar , Peter Wambi , Robert Castro , Rutuja Nerurkar , Mingyue Wang , Jacob Wohlstadter , Molly F Franke , Beate Kampmann , Aarti Kinikar , Heather J Zar , Mark Segal , Midori Kato-Maeda , Jeffrey M Collins , Danielle Swaney , Adithya Cattamanchi , Joel D Ernst , Eric Wobudeya , George Sigal , The Combo Study medRxiv 2026.08.28.26361530; doi: https://doi.org/10.64898/2026.08.28.26361530 Share This Article: Copy Citation Tools The accuracy of urine-based mycobacterial antigens to detect childhood tuberculosis using an ultrasensitive immunoassay Esin Nkereuwem , Salvia Misaghian , Devan Jaganath , Roger I Calderon , Juaneta Luiz , Mandar Paradkar , Peter Wambi , Robert Castro , Rutuja Nerurkar , Mingyue Wang , Jacob Wohlstadter , Molly F Franke , Beate Kampmann , Aarti Kinikar , Heather J Zar , Mark Segal , Midori Kato-Maeda , Jeffrey M Collins , Danielle Swaney , Adithya Cattamanchi , Joel D Ernst , Eric Wobudeya , George Sigal , The Combo Study medRxiv 2026.08.28.26361530; doi: https://doi.org/10.64898/2026.08.28.26361530 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (614) Allergy and Immunology (896) Anesthesia (327) Cardiovascular Medicine (4772) Dentistry and Oral Medicine (474) Dermatology (407) Emergency Medicine (643) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1615) Epidemiology (15838) Forensic Medicine (32) Gastroenterology (1195) Genetic and Genomic Medicine (6984) Geriatric Medicine (727) Health Economics (1057) Health Informatics (4988) Health Policy (1427) Health Systems and Quality Improvement (1738) Hematology (581) HIV/AIDS (1336) Infectious Diseases (except HIV/AIDS) (16245) Intensive Care and Critical Care Medicine (1161) Medical Education (663) Medical Ethics (151) Nephrology (721) Neurology (7196) Nursing (364) Nutrition (1074) Obstetrics and Gynecology (1232) Occupational and Environmental Health (1001) Oncology (3575) Ophthalmology (1038) Orthopedics (393) Otolaryngology (446) Pain Medicine (466) Palliative Medicine (139) Pathology (704) Pediatrics (1774) Pharmacology and Therapeutics (733) Primary Care Research (759) Psychiatry and Clinical Psychology (5836) Public and Global Health (9694) Radiology and Imaging (2389) Rehabilitation Medicine and Physical Therapy (1435) Respiratory Medicine (1243) Rheumatology (635) Sexual and Reproductive Health (767) Sports Medicine (577) Surgery (767) Toxicology (107) Transplantation (303) Urology (286)
## Related Clinical Research

- [Determinants of Favorable MDR-TB Treatment Outcomes in Zambia, 2018–2022](https://medichelpline.com/clinical-feed/plos-one-16-determinants-of-favorable-treatment-outcomes-in-multidrug-resistant.md)
- [Predictors of Healthcare Costs for Commercially Insured Adults with Tuberculosis in the US (2013–2](https://medichelpline.com/clinical-feed/medrxiv-0-predictors-of-healthcare-costs-among-commercially-insured-persons-with.md)
- [District-level HIV and TB vulnerability to climate hazards in South Africa: a composite index anal](https://medichelpline.com/clinical-feed/medrxiv-4-district-level-hiv-and-tb-health-system-vulnerability-to-climate-and-weather.md)
- [Epidemiology and species-level susceptibility of Candida infections in a Tolima tertiary hospital](https://medichelpline.com/clinical-feed/plos-one-4-clinical-and-microbiological-epidemiology-of-candida-infections-in-a-high.md)
- [Gut microbiota and tuberculosis: article content not provided—metadata and access details](https://medichelpline.com/clinical-feed/frontiers-in-immunology-14-gut-microbiota-driven-immunomodulation-in-tuberculosis-targeting-dysbiosis-to.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.